Research published in an international journal and reviewed by European regulators found an approximately two fold increase in the relative risk of NAION among semaglutide users, although the overall risk remains low
For each production lot, brands should define identity testing, assay method, microbiological limits, heavy-metal limits, moisture control, and packaging stability requirements in the master manufacturing record
Do not skip doses without talking to your provider first
By understanding its uses, benefits, and potential considerations, patients can make informed decisions about their post-surgical care.
Be transparent and mention tirzepatide (Mounjaro, Zepbound, or compounded formulations) by name, along with the dose and how long you've been taking it
[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, et al